Načítá se...
Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada
BACKGROUND: Outcomes for patients with metastatic colorectal cancer (mcrc) are improving with the introduction of new treatments. Treatment for patients who are still fit after failure of all available therapies represents a significant unmet need. In the present study, we analyzed real-world treatm...
Uloženo v:
| Vydáno v: | Curr Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Multimed Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821111/ https://ncbi.nlm.nih.gov/pubmed/31708650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.5107 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|